The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review
Abstract
INTRODUCTION: Prevalence estimates of osteopenia and osteoporosis (reduced bone mineral density; BMD) in HIV-infected patients and the role of antiretroviral therapy (ART) varies in the literature. METHODS: We conducted a meta-analytical review of cross-sectional studies published in English to determine the pooled odds ratios (OR) of reduced BMD and osteoporosis in the following groups: HIV-positive versus HIV-negative; ART-treated versus ART-naive; protease inhibitor (PI)-treated versus PI-untreated. We searched the MEDLINE, PubMed, and EMBASE databases for eligible references between January 1966 and November 2005. Random effects models were used to generate pooled OR estimates and confidence intervals. RESULTS: Of 37 articles identified, 20 met the inclusion criteria. Of the 884 HIV-infected patients, 67% had reduced BMD, of whom 15% had osteoporosis, yielding a pooled OR of 6.4 and 3.7, respectively, compared with HIV-uninfected controls (n = 654) using 11 studies with available data. Compared with ART-naive patients (n = 202, 10 studies), ART-treated individuals (n = 824) had a 2.5-fold increased odds of prevalent reduced BMD. The risk of prevalent osteoporosis (seven studies) was similarly elevated in ART-treated individuals. Compared with non-PI-treated HIV patients (n = 410, 14 studies), PI-treated patients (n = 791) had increased odds of reduced BMD and osteoporosis (12 studies). Few studies adjusted for important covariates such as HIV disease severity or treatment duration. CONCLUSION: The prevalence of osteoporosis in HIV-infected individuals is more than three times greater compared with HIV-uninfected controls. ART-exposed and PI-exposed individuals had a higher prevalence of reduced BMD and osteoporosis compared with their respective controls. The influence of other disease and treatment variables on these estimates could not be determined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis
(1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90218-e · Cited by 2,874
Gallant, J. E. (2004) · JAMA · doi:10.1001/jama.292.2.191 · Cited by 1,341 · cited 4×
“In a large randomized, double-blinded trial comparing the safety and efficacy of tenofovir to stavudine with a lamivudine and efavirenz backbone (n1⁄4 602) [4], significant BMD reductions in the spine and hip were observed in both treatment groups over the 144-week study interval.”
BackgroundResultInfluentialConsensus Development Conference: A Cross-Cultural Study
Larsen, J. K., & Rogers, E. M. (1984) · Knowledge · doi:10.1177/107554708400500406 · Cited by 751
Kopera, H., & Ziegler, R. (1989) · Klinische Wochenschrift · doi:10.1007/bf01719785 · Cited by 749
Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy
Tebas, P., Powderly, W. G., Claxton, S., Marin, D., Tantisiriwat, W., Teitelbaum, S. L., & Yarasheski, K. E. (2000) · AIDS · doi:10.1097/00002030-200003100-00005 · Cited by 532
Schambelan, M., Benson, C. A., Carr, A., Currier, J. S., Dubé, M. P., Gerber, J. G., Grinspoon, S. K., Grunfeld, C., Kotler, D. P., Mulligan, K., et al. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200211010-00001 · Cited by 379
Mallon, P. W., Miller, J., Cooper, D. A., & Carr, A. (2003) · AIDS · doi:10.1097/00002030-200305020-00005 · Cited by 313
Mondy, K., Yarasheski, K., Powderly, W. G., Whyte, M., Claxton, S., DeMarco, D., Hoffmann, M., & Tebas, P. (2003) · Clinical Infectious Diseases · doi:10.1086/367569 · Cited by 305
Official Positions of the International Society for Clinical Densitometry
Lewiecki, E. M., Watts, N. B., McClung, M. R., Petak, S. M., Bachrach, L. K., Shepherd, J. A., & Downs, R. W. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0124 · Cited by 291
Cited by
HIV Infection, Inflammation, Immunosenescence, and Aging
Deeks, S. G. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-042909-093756 · Cited by 1,349
Future challenges for clinical care of an ageing population infected with HIV: a modelling study
Smit, M., Brinkman, K., Geerlings, S., Smit, C., Thyagarajan, K., Sighem, A. V., de Wolf, F., & Hallett, T. B. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00056-0 · Cited by 908
Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study
Hasse, B., Ledergerber, B., Furrer, H., Battegay, M., Hirschel, B., Cavassini, M., Bertisch, B., Bernasconi, E., Weber, R., & Study, T. S. H. C. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir626 · Cited by 608
Sax, P. E., Wohl, D., Yin, M. T., Post, F., DeJesus, E., Saag, M., Pozniak, A., Thompson, M., Podzamczer, D., Molina, J. M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60616-x · Cited by 601
McComsey, G. A., Kitch, D., Daar, E. S., Tierney, C., Jahed, N. C., Tebas, P., Myers, L., Melbourne, K., Ha, B., & Sax, P. E. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir188 · Cited by 495
Triant, V. A., Brown, T. T., Lee, H., & Grinspoon, S. K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0828 · Cited by 490
Self-citationAntiretroviral therapy and management of HIV infection
Volberding, P. A., & Deeks, S. G. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60676-9 · Cited by 449
Stellbrink, H., Orkin, C., Arribas, J. R., Compston, J., Gerstoft, J., Van Wijngaerden, E., Lazzarin, A., Rizzardini, G., Sprenger, H. G., Lambert, J., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/656417 · Cited by 405
Bone Disease in HIV Infection: A Practical Review and Recommendations for HIV Care Providers
McComsey, G. A., Tebas, P., Shane, E., Yin, M. T., Overton, E. T., Huang, J. S., Aldrovandi, G. M., Cardoso, S. W., Santana, J. L., & Brown, T. T. (2010) · Clinical Infectious Diseases · doi:10.1086/656412 · Cited by 396
Self-citationRay, A. S., Fordyce, M. W., & Hitchcock, M. J. M. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2015.11.009 · Cited by 392
Residual Immune Dysregulation Syndrome in Treated HIV infection
Lederman, M. M., Funderburg, N. T., Sekaly, R. P., Klatt, N. R., & Hunt, P. W. (2013) · Advances in Immunology · doi:10.1016/b978-0-12-407707-2.00002-3 · Cited by 348
Bedimo, R., Maalouf, N. M., Zhang, S., Drechsler, H., & Tebas, P. (2012) · AIDS · doi:10.1097/qad.0b013e32835192ae · Cited by 324
Brown, T. T., McComsey, G. A., King, M. S., Qaqish, R. B., Bernstein, B. M., & da Silva, B. A. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181adce44 · Cited by 316
Self-citationHIV and aging: time for a new paradigm.
Justice, A. C. (2010) · Current HIV/AIDS Reports · doi:10.1007/s11904-010-0041-9 · Cited by 309
Tenofovir‐associated renal and bone toxicity
Woodward, C., Hall, A., Williams, I., Madge, S., Copas, A., Nair, D., Edwards, S., Johnson, M., & Connolly, J. (2009) · HIV Medicine · doi:10.1111/j.1468-1293.2009.00716.x · Cited by 291
Ageing and inflammation in patients with HIV infection
Nasi, M., De Biasi, S., Gibellini, L., Bianchini, E., Pecorini, S., Bacca, V, Guaraldi, G., Mussini, C., Pinti, M., & Cossarizza, A. (2016) · Clinical and Experimental Immunology · doi:10.1111/cei.12814 · Cited by 277
Drug-induced Osteoporosis: Mechanisms and Clinical Implications
Mazziotti, G., Canalis, E., & Giustina, A. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.02.028 · Cited by 262
Increased Risk of Fragility Fractures among HIV Infected Compared to Uninfected Male Veterans
Womack, J. A., Goulet, J. L., Gibert, C., Brandt, C., Chang, C. C., Gulanski, B., Fraenkel, L., Mattocks, K., Rimland, D., Rodriguez-Barradas, M. C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017217 · Cited by 261
Weitzmann, M. N. (2013) · Scientifica · doi:10.1155/2013/125705 · Cited by 259
Young, B., Dao, C. N., Buchacz, K., Baker, R., Brooks, J. T., & the HIV Outpatient Study (HOPS) Investigators (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq242 · Cited by 253
GERSTNER, G., DAMIANO, M. L., TOM, A., WORMAN, C., SCHULTZ, W., RECHT, M., & STOPECK, A. T. (2009) · Haemophilia · doi:10.1111/j.1365-2516.2008.01963.x · Cited by 148
Beaupere, C., Garcia, M., Larghero, J., Fève, B., Capeau, J., & Lagathu, C. (2015) · Aging Cell · doi:10.1111/acel.12308 · Cited by 85
Bernardino, J. I., Mocroft, A., Mallon, P. W., Wallet, C., Gerstoft, J., Russell, C., Reiss, P., Katlama, C., De Wit, S., Richert, L., et al. (2015) · The Lancet HIV · doi:10.1016/s2352-3018(15)00181-2 · Cited by 76
Hernandez‐Vallejo, S. J., Beaupere, C., Larghero, J., Capeau, J., & Lagathu, C. (2013) · Aging Cell · doi:10.1111/acel.12119 · Cited by 70
The struggle of a good friend getting old: cellular senescence in viral responses and therapy
Kohli, J., Veenstra, I., & Demaria, M. (2021) · The EMBO Reports · doi:10.15252/embr.202052243 · Cited by 52
“…reported to display reduced BMD and increased risk of developing osteoporosis, although there is some divergence as to whether this phenomenon occurs due to the HIV retrovirus or protease inhibitor therapy (Tebas et al , 2000; Bruera et al , 2003; Amiel et al , 2004; Brown & Qaqish, 2006).”
Casado, J. L., Bañon, S., Andrés, R., Perez-Elías, M. J., Moreno, A., & Moreno, S. (2014) · Osteoporosis International · doi:10.1007/s00198-013-2506-3 · Cited by 44
Interactions of B-lymphocytes and bone cells in health and disease
Grčević, D., Sanjay, A., & Lorenzo, J. (2023) · Bone · doi:10.1016/j.bone.2021.116296 · Cited by 36
Metadata
- Authors
- Brown, T. T., & Qaqish, R. B.
- Venue
- AIDS
- Published
- 2006-11-14
- Volume
- 20
- Issue
- 17
- Pages
- 2165-2174
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2025740330
- Cited by
- 925
- References
- 47
- FWCI
- 31.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.